Chris WoodAIThe paradox of AI in lung nodulesIn this column, RevealDx CEO Chris Wood describes a pathway to reducing lung cancer mortality that isn't being fully utilized in the U.S.November 24, 2025Page 1 of 1Top StoriesRadiation Oncology/TherapyPSMA-PET scans guide LDR brachytherapy in prostate cancerAt last follow-up, 79% of patients were without evidence of disease.BreastHalf of false-negative DBT exams are missed cancersNuclear MedicineGE HealthCare to acquire Sofie Biosciences for $945MRadiology EducationEarly exposure program introduces college students to imaging careersSponsor ContentFree Webinar: CT Contrast Injection Reimagined
